Join | Home | Print Page | Contact Us | Sign In
Webinar: Valley Fever Vaccine & Epidemiology Updates 7-22-20
Register Tell a Friend About This EventTell a Friend
Webinar: Valley Fever Vaccine & Epidemiology Updates 7-22-20

 Export to Your Calendar 7/22/2020 to 8/10/2020
When: Live On: Wednesday, July 22, 2020
Where: Virtual Webinar
United States
Contact: 602-242-7936

Online registration is available until: 8/10/2020
« Go to Upcoming Event List  

Webinar Details 

Register to watch the recorded webinar "Valley Fever Vaccine & Epidemiology Updates". After registering you will receive an emailed confirmation containing access information to view the webinar & instructions on completing a 3-question quiz to earn CE credit. 


Join us on Wednesday, July 22, 2020 from 6:00 - 7:00 pm for the AzVMA's Zoom Webinar, Valley Fever Vaccine & Epidemiology Updates


Discussion Topics:

  • A preventive vaccine in dogs is well underway toward becoming available
  • Regulatory hurdles, formulation will affect how long it takes
  • Coccidioidomycosis is increasing significantly in areas with low or very few cases
  • Reporting could improve our understanding in Arizona
  • Valley fever will continue to have a high impact and research remains vital to improving care for animals in endemic areas

Webinar Rates:

  • AzVMA Member: $25
  • Non-member: $45
  • VHCTAz Member & Students: $10
  • Non-VHCTAz Member: $20

Important Webinar Information:

  • Approved for 1 CE hour by the Arizona Academy of Veterinary Practice (for veterinarians & technicians).
  • Note: CE credit will only be awarded to those who watch the entire webinar.
  • If unable to watch the interactive, live webinar you may earn CE credit by viewing the recorded webinar and completing a 3-question quiz. Instructions for the quiz will be provided via email from
  • Zoom TutorialJoining and participating in a webinar (attendee)




Lisa Shubitz, BS, DVM

Valley Fever Center for Excellence, The University of Arizona

Dr. Lisa Shubitz has been involved with Valley Fever research at the Valley Fever Center for Excellence since 1996. Research includes vaccines to prevent valley fever in humans and dogs, understand the immunology of infection and resistance, epidemiology of valley fever in dogs, and experimental and clinical research of new antifungal drugs, including clinical trials that have benefitted dogs. The focus of research Dr. Shubitz is involved in is translational, studies that directly or indirectly seek to improve the lives of animals and humans. Recently, the Shubitz lab completed a study to address therapeutic dosages of fluconazole in alpacas, a species with a high mortality from valley fever.



Supported By

*AzVMA Premier Sponsor*



Cancellation Policy: Cancellations before 7-19-20 will receive refunds in full. No-shows or cancellations received after 7-19-20 will be charged the full amount.